General Info

Hamilton BioVentures is a venture capital firm investing in talented entrepreneurs bringing new Life Science technology enterprises to market. The company invests in companies developing dramatically better treatments (biopharmaceuticals and medical devices) for major human diseases and other medical conditions. Its investments generally take the form of direct equity in early-stage companies located on the West Coast. The company s portfolio comprises of Angstrom, CargoTech, Converge, Egea Biosciences, Entropic Communications, Q3DM, Transcept Pharmaceuticals and Troika Networks.